News
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
Truvada, also made by Gilead ... we could see disparities just get worse.” Much of the CDC’s HIV-prevention and -surveillance budget is distributed in grants to state and local health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results